<SEC-DOCUMENT>0001193125-17-335943-index.html : 20171107
<SEC-HEADER>0001193125-17-335943.hdr.sgml : 20171107
<ACCEPTANCE-DATETIME>20171107173047
ACCESSION NUMBER:		0001193125-17-335943
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20171107
DATE AS OF CHANGE:		20171107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-221402
		FILM NUMBER:		171184517

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>d489256ds3.htm
<DESCRIPTION>FORM S-3
<TEXT>
Document 1 - file: d489256ds3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d489256dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
Document 2 - file: d489256dex11.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d489256dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
Document 3 - file: d489256dex42.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d489256dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
Document 4 - file: d489256dex43.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>d489256dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 5 - file: d489256dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>6
<FILENAME>d489256dex121.htm
<DESCRIPTION>EX-12.1
<TEXT>
Document 6 - file: d489256dex121.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>d489256dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 7 - file: d489256dex231.htm

</DOCUMENT>
</SEC-DOCUMENT>